Advanced Hemostatic Systems for Enhanced Bleeding Control
Legal Citation
Summary of the Inventive Concept
The invention integrates anion exchanger-based hemostatic compositions with cutting-edge technologies like AI, IoT, blockchain, and nanomaterials to create a new generation of hemostatic systems with improved efficacy, real-time monitoring, and enhanced delivery.
Background and Problem Solved
The original patent disclosed hemostatic compositions comprising an anion exchanger and calcium salt. However, these compositions had limitations in terms of real-time monitoring, controlled release, and bleeding risk prediction. The new inventive concept addresses these limitations by combining the patented composition with distinct technologies to create a more powerful and efficient system.
Detailed Description of the Inventive Concept
The inventive concept comprises a wearable device with a sensor for detecting bleeding and a dispenser for administering the hemostatic composition. The system utilizes machine learning algorithms to predict bleeding risk and optimize composition delivery. Additionally, the composition can be enhanced with nanomaterials for controlled release and improved efficacy. The system can be integrated with a blockchain-based tracking system for secure monitoring and data management.
Novelty and Inventive Step
The new claims introduce the synergistic combination of anion exchanger-based hemostatic compositions with AI, IoT, blockchain, and nanomaterials, which provides a new and non-obvious solution for bleeding control. The integration of these technologies enables real-time monitoring, controlled release, and bleeding risk prediction, making the system more effective and efficient than the original patent.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept could include the use of different AI algorithms, various IoT sensors, or distinct nanomaterials. The system could also be adapted for use in different medical settings, such as emergency response or surgical procedures.
Potential Commercial Applications and Market
The inventive concept has significant commercial potential in the medical device and pharmaceutical industries, particularly in the areas of emergency response, surgical hemostasis, and wound care. The system's ability to provide real-time monitoring and controlled release could revolutionize the field of bleeding control, offering a new standard of care for patients.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Medical devices and hemostatic technologies, specifically focusing on compositions and systems for controlling bleeding, with expertise in materials science, biomedical engineering, and medical device design
Person of Ordinary Skill (PHOSITA) Profile
A professional with advanced degrees in biomedical engineering or chemical engineering, experienced in developing medical technologies, familiar with hemostatic materials, sensor technologies, and emerging medical device integration strategies
Obviousness Rationale
A PHOSITA would recognize that integrating modern technologies like AI, IoT, and nanomaterials with existing hemostatic compositions represents a predictable extension of known medical device innovation strategies. The source patent's fundamental hemostatic composition provides a clear technical foundation for technological enhancement. The proposed variations represent logical combinations of known techniques in medical monitoring and drug delivery systems.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,564 |
|---|---|
| Title | Hemostatic composition comprising an anion exchanger and a calcium salt |
| Assignee(s) | Omrix Biopharmaceuticals Ltd. |